0000914062-13-000365.txt : 20131203 0000914062-13-000365.hdr.sgml : 20131203 20131203170455 ACCESSION NUMBER: 0000914062-13-000365 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131202 FILED AS OF DATE: 20131203 DATE AS OF CHANGE: 20131203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC CENTRAL INDEX KEY: 0001133416 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043562325 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD CITY: NORCROSS STATE: GA ZIP: 30071 BUSINESS PHONE: 678-620-3186 MAIL ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD CITY: NORCROSS STATE: GA ZIP: 30071 FORMER COMPANY: FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAULDIN JOHN F CENTRAL INDEX KEY: 0001522480 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31791 FILM NUMBER: 131255032 MAIL ADDRESS: STREET 1: 3204 BEVERLY DRIVE CITY: DALLAS STATE: TX ZIP: 75205 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-12-02 0001133416 GALECTIN THERAPEUTICS INC GALT 0001522480 MAULDIN JOHN F C/O GALECTIN THERAPEUTICS INC. 4960 PEACHTREE INDUSTRIAL BLVD, STE 240 NORCROSS GA 30071 1 0 0 0 Common Stock 2013-12-02 4 P 0 609 8.1967 A 17456 D Common Stock 4947 I By Trust The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2013. Reflects weighted average price. Range of prices were between $8.19 and $8.20. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. /s/ Jack W. Callicutt, Attorney-in-Fact 2013-12-03